What is the definition of Myeloperoxidase Deficiency?

Myeloperoxidase (MPO) deficiency is a rare inherited (genetic) primary immunodeficiency disorder characterized by a reduction or lack of the immune enzyme, myeloperoxidase, in white blood cells (neutrophils and monocytes). Myeloperoxidase deficiency causes an impaired ability for the immune system to kill microbes.

What are the symptoms for Myeloperoxidase Deficiency?

Most individuals with myeloperoxidase deficiency do not have any symptoms. However, myeloperoxidase deficiency may lead to severe infections, in particular fungal infections, such as Candida albicans, especially in individuals who also have diabetes mellitus.

What are the current treatments for Myeloperoxidase Deficiency?

Most individuals with myeloperoxidase deficiency do not need any treatment. Patients who also have diabetes mellitus and myeloperoxidase deficiency may need rapid treatment with antibiotics for localized and systemic infections, especially fungal infections, such as Candida albicans.

There is no recent research available for this condition. Please check back because thousands of new papers are published every week and we strive to find and display the most recent relevant research as soon as it is available.

There are no recent clinical trials available for this condition. Please check back because new trials are being conducted frequently.